MedPath

Observational Feasibility Study of Home-based Training With Therabands in PAD-patients

Not Applicable
Completed
Conditions
Peripheral Artery Disease
Intermittent Claudication
Interventions
Behavioral: aerobic+resistance exercise training program
Registration Number
NCT04043546
Lead Sponsor
KU Leuven
Brief Summary

The study is an observational feasibility study to evaluate the feasibility of a combined aerobic+resistance training program in patients with IC.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • age ≥ 50 yrs;
  • ankle-brachial index (ABI) ≤ 0.9 in one or two legs;
  • Fontaine stage II (Rutherford I 1-3) of PAD (new onset or conservatively treated);
  • body mass index <35 kg/m 2 ;
  • resting systolic blood pressure (BP) <160 mmHg and diastolic BP <105 mmHg;
  • ability to walk at least 2 min at 2.0 mph;
  • ability to undertake an incremental treadmill test;
  • decrease of at least 15% in ABI after a maximal treadmill test;
  • not currently engaging in any regular exercise program.
Exclusion Criteria
  • exercise induced signs of myocardial ischemia or complex ventricular arrhythmias;
  • no access to laptop or internet;
  • no medical clearance for exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Exercise interventionaerobic+resistance exercise training program-
Primary Outcome Measures
NameTimeMethod
user satisfaction4 weeks

self-developed questionnaire based evaluation of user satisfaction

walking distance4 weeks

pain free and maximal walking distance are recorded using the Gardner treadmill protocol.

Secondary Outcome Measures
NameTimeMethod
Physical activity2 months

Physical activity, defined total active energy expenditure (kcal) is obtained from objective measurement of physical activity during 7 consecutive days using the Sensewear device.

Trial Locations

Locations (1)

KU Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath